{"organizations": [], "uuid": "0733a9f7ea8b226245d4bf21d5f7cd8bf2993da3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-astellas-acquires-universal-cells/brief-astellas-acquires-universal-cells-inc-idUSASB0C5KW", "country": "US", "domain_rank": 408, "title": "BRIEF-Astellas acquires Universal Cells Inc", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T03:02:00.000+02:00", "replies_count": 0, "uuid": "0733a9f7ea8b226245d4bf21d5f7cd8bf2993da3"}, "author": "", "url": "https://www.reuters.com/article/brief-astellas-acquires-universal-cells/brief-astellas-acquires-universal-cells-inc-idUSASB0C5KW", "ord_in_thread": 0, "title": "BRIEF-Astellas acquires Universal Cells Inc", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "universal cells inc", "sentiment": "negative"}, {"name": "reuters) - astellas pharma inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - Astellas Pharma Inc:\n* ASTELLAS ACQUIRES UNIVERSAL CELLS, INC. * ASTELLAS WILL PAY UP TO $102.5 MILLION OF UPFRONT AND MILESTONES TO ACQUIRE 100 PERCENT OWNERSHIP OF UNIVERSAL CELLS\n* ‍IMPACT OF TRANSACTION ON ASTELLAS’ FINANCIAL RESULTS FOR FISCAL YEAR ENDING MARCH 31, 2018 WILL BE IMMATERIAL​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-14T03:02:00.000+02:00", "crawled": "2018-02-14T03:22:27.009+02:00", "highlightTitle": ""}